These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

765 related articles for article (PubMed ID: 17237659)

  • 1. Foundations of opioid risk management.
    Katz NP; Adams EH; Benneyan JC; Birnbaum HG; Budman SH; Buzzeo RW; Carr DB; Cicero TJ; Gourlay D; Inciardi JA; Joranson DE; Kesslick J; Lande SD
    Clin J Pain; 2007 Feb; 23(2):103-18. PubMed ID: 17237659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The burden of the nonmedical use of prescription opioid analgesics.
    Gilson AM; Kreis PG
    Pain Med; 2009 Jul; 10 Suppl 2():S89-100. PubMed ID: 19691688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pain management in primary care: strategies to mitigate opioid misuse, abuse, and diversion.
    McCarberg BH
    Postgrad Med; 2011 Mar; 123(2):119-30. PubMed ID: 21474900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wanted: a public health approach to prescription opioid abuse and diversion.
    Joranson DE; Gilson AM
    Pharmacoepidemiol Drug Saf; 2006 Sep; 15(9):632-4. PubMed ID: 16862603
    [No Abstract]   [Full Text] [Related]  

  • 5. The development of a comprehensive risk-management program for prescription opioid analgesics: researched abuse, diversion and addiction-related surveillance (RADARS).
    Cicero TJ; Dart RC; Inciardi JA; Woody GE; Schnoll S; Muñoz A
    Pain Med; 2007 Mar; 8(2):157-70. PubMed ID: 17305687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid risk management: understanding FDA mandated risk evaluation and mitigation strategies (REMS).
    Sloan PA
    J Opioid Manag; 2009; 5(3):131-3. PubMed ID: 19662921
    [No Abstract]   [Full Text] [Related]  

  • 7. Update on abuse-resistant and abuse-deterrent approaches to opioid formulations.
    Webster L
    Pain Med; 2009 Jul; 10 Suppl 2():S124-33. PubMed ID: 19691683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of side effects of prolonged low or moderate dose opioid therapy with concomitant benzodiazepine and/or antidepressant therapy in chronic non-cancer pain.
    Manchikanti L; Manchikanti KN; Pampati V; Cash KA
    Pain Physician; 2009; 12(1):259-67. PubMed ID: 19165308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Volume of prescription opioids used nonmedically in the United States.
    Katz NP; Birnbaum HG; Castor A
    J Pain Palliat Care Pharmacother; 2010 Jun; 24(2):141-4. PubMed ID: 20504136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. National drug control policy and prescription drug abuse: facts and fallacies.
    Manchikanti L
    Pain Physician; 2007 May; 10(3):399-424. PubMed ID: 17525776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997-2002.
    Gilson AM; Ryan KM; Joranson DE; Dahl JL
    J Pain Symptom Manage; 2004 Aug; 28(2):176-88. PubMed ID: 15276196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pain treatment, drug diversion, and the casualties of war.
    Burgess F
    Pain Med; 2006; 7(6):474-5. PubMed ID: 17112360
    [No Abstract]   [Full Text] [Related]  

  • 13. Pain management failing as fears of prescription drug abuse rise.
    J Pain Palliat Care Pharmacother; 2010 Jun; 24(2):182-3. PubMed ID: 20504150
    [No Abstract]   [Full Text] [Related]  

  • 14. Issues and critiques of the forthcoming risk evaluation and mitigation strategy (REMS) for opioids in pain management.
    Peppin JF; Coleman JJ; Kirsh KL
    Issues Law Med; 2011; 27(2):91-119. PubMed ID: 22372206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OxyContin: maintaining availability and efficacy while preventing diversion and abuse.
    Regan JJ; Alderson A
    Tenn Med; 2003 Feb; 96(2):88-90. PubMed ID: 12645369
    [No Abstract]   [Full Text] [Related]  

  • 16. Opioid therapy and prescription drug diversion.
    Burgess FW; Pawasauskas J
    Med Health R I; 2008 Sep; 91(9):268-70. PubMed ID: 18834042
    [No Abstract]   [Full Text] [Related]  

  • 17. The opioid renewal clinic: a primary care, managed approach to opioid therapy in chronic pain patients at risk for substance abuse.
    Wiedemer NL; Harden PS; Arndt IO; Gallagher RM
    Pain Med; 2007; 8(7):573-84. PubMed ID: 17883742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Major increases in opioid analgesic abuse in the United States: concerns and strategies.
    Compton WM; Volkow ND
    Drug Alcohol Depend; 2006 Feb; 81(2):103-7. PubMed ID: 16023304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical strategies for the primary health care professional to minimize prescription opioid abuse.
    Gudin JA
    Postgrad Med; 2012 May; 124(3):131-8. PubMed ID: 22691907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of common screening methods for predicting aberrant drug-related behavior among patients receiving opioids for chronic pain management.
    Moore TM; Jones T; Browder JH; Daffron S; Passik SD
    Pain Med; 2009 Nov; 10(8):1426-33. PubMed ID: 20021601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.